华纳药厂：聚乙二醇钠钾散获得药品注册证书

Core Viewpoint - Warner Pharmaceuticals has received a drug registration certificate from the National Medical Products Administration for polyethylene glycol sodium potassium powder, which is intended for the treatment of chronic constipation and fecal impaction [1] Company Summary - Warner Pharmaceuticals announced the receipt of a drug registration certificate for a new product [1] - The product is specifically designed to address chronic constipation and fecal impaction [1] Industry Summary - The approval of this product indicates a potential growth opportunity in the market for treatments related to gastrointestinal disorders [1]